Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the pentavalent market grown over the years?

In recent times, the size of the pentavalent market has seen consistent growth. The market is predicted to increase from $2.62 billion in 2024 to $2.73 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. The expansion during the historic period can be credited to worldwide immunization efforts, government-backed vaccination schemes, combating various diseases, heightened public health consciousness, along with international collaboration and financial support.

What Is the forecasted market size and growth rate for the pentavalent market?

Get your pentavalent market report here!

https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

What are the major factors driving growth in the pentavalent market?

It is anticipated that the growing incidence of diphtheria will spur the expansion of the pentavalent market. The bacterium known as Corynebacterium diphtheriae triggers the extremely infectious and serious disease called diphtheria, which causes significant difficulties in eating and breathing and can also lead to skin ulcers. The pentavalent vaccine is designed to safeguard children against diphtheria via a 3-dose pentavalent immunization schedule, thereby increasing the demand for pentavalent vaccines due to the escalating incidences of diphtheria. In 2022, the World Health Organization, a specialized agency of the United Nations located in Switzerland, reported an unusually large case rate of diphtheria through their International Health Regulations (IHR) recording process, particularly in June and August 2022. A total of seven countries reported 144 diphtheria cases, many of them being refugees. Out of these, 97 (69%) were deemed to be clinically compatible, 44 (31%) were successfully determined to be toxigenic diphtheria cases via lab verification, and 3 (2%) were suspected instances. Consequently, the growing incidence of diphtheria is propelling the pentavalent market’s growth.

What key areas define the segmentation of the global pentavalent Market?

The pentavalent market covered in this report is segmented –

1) By Type: Sodium Stibogluconate, Meglumine Antimoniate

2) By Formulation Type: Lyophilized, Liquid

3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Sodium Stibogluconate: Injectable Form, Oral Form, Other Formulations

2) By Meglumine Antimoniate: Injectable Form, Oral Form, Other Formulations

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

What are the top market players propelling the growth of the pentavalent industry?

Major companies operating in the pentavalent market include Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

What are the key trends shaping the future of the pentavalent market?

Prominent corporations in the pentavalent market encompass Pfizer Inc., Merck & Co Inc., Sanofi SA, GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, PT Bio Farma (Persero), Shantha Biotechnics Limited, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, PanGen Biotech Inc., Bharat Biotech International Limited, Vacsera Ltd., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9104

What regions are dominating the pentavalent market growth?

Asia-Pacific was the largest region in the pentavalent market in 2024. The regions covered in the pentavalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Thermoplastic Composite Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/thermoplastic-composite-global-market-report

Ceramic Matrix Composites Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ceramic-matrix-composites-global-market-report

Activated Carbon Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/activated-carbon-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: